Enhanced tumor therapy using vaccinia virus strain GLV-1h68 in combination with a β-galactosidase-activatable prodrug seco-analog of duocarmycin SA (Q34137180)
Jump to navigation
Jump to search
scientific article published on September 10, 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Enhanced tumor therapy using vaccinia virus strain GLV-1h68 in combination with a β-galactosidase-activatable prodrug seco-analog of duocarmycin SA |
scientific article published on September 10, 2010 |
Statements
1 reference
Enhanced tumor therapy using vaccinia virus strain GLV-1h68 in combination with a β-galactosidase-activatable prodrug seco-analog of duocarmycin SA (English)
1 reference
C. M. Seubert
J. Stritzker
M. Hess
U. Donat
J. B. Sturm
N. Chen
J. M. von Hof
B. Krewer
L. F. Tietze
I. Gentschev
10 September 2010
1 reference
1 reference
1 reference
18
1 reference
42-52
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference